Tianjin Lisheng Pharmaceutical Co Ltd (002393) — Capital Reinvestment Ratio
Tianjin Lisheng Pharmaceutical Co Ltd (002393) has a Capital Reinvestment Ratio of 0.07x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥287.81 Million) in capital expenditures (CN¥20.11 Million). See net asset quality index of Tianjin Lisheng Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Lisheng Pharmaceutical Co Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Tianjin Lisheng Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. Check cash flow reinvestment rate of Tianjin Lisheng Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Tianjin Lisheng Pharmaceutical Co Ltd from 2007 to 2025. For live market cap and broader valuation context, see Tianjin Lisheng Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥451.85 Million | CN¥37.46 Million | ▼ -86.4% |
| 2024 | 0.61x | CN¥88.26 Million | CN¥53.75 Million | ▲ +106.7% |
| 2023 | 0.29x | CN¥209.51 Million | CN¥61.72 Million | ▲ +138.6% |
| 2022 | 0.12x | CN¥331.38 Million | CN¥40.91 Million | ▼ -72.5% |
| 2021 | 0.45x | CN¥196.34 Million | CN¥88.24 Million | ▼ -65.9% |
| 2020 | 1.32x | CN¥76.37 Million | CN¥100.66 Million | ▲ +291.0% |
| 2019 | 0.34x | CN¥268.33 Million | CN¥90.46 Million | ▼ -47.5% |
| 2018 | 0.64x | CN¥162.69 Million | CN¥104.43 Million | ▲ +129.7% |
| 2017 | 0.28x | CN¥179.25 Million | CN¥50.09 Million | ▼ -64.6% |
| 2016 | 0.79x | CN¥173.60 Million | CN¥137.20 Million | ▼ -23.5% |
| 2015 | 1.03x | CN¥198.13 Million | CN¥204.60 Million | ▼ -74.3% |
| 2014 | 4.02x | CN¥72.24 Million | CN¥290.65 Million | ▲ +272.2% |
| 2013 | 1.08x | CN¥289.62 Million | CN¥313.11 Million | ▲ +20.8% |
| 2012 | 0.89x | CN¥250.72 Million | CN¥224.35 Million | ▼ -27.4% |
| 2011 | 1.23x | CN¥134.58 Million | CN¥165.94 Million | ▲ +230.1% |
| 2010 | 0.37x | CN¥186.55 Million | CN¥69.69 Million | ▲ +316.4% |
| 2009 | 0.09x | CN¥196.14 Million | CN¥17.60 Million | ▼ -82.5% |
| 2008 | 0.51x | CN¥126.59 Million | CN¥64.86 Million | ▲ +543.9% |
| 2007 | 0.08x | CN¥174.94 Million | CN¥13.92 Million | — |